News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
The Basic Research in Cancer Health Disparities Program – NCI Center to Reduce Cancer Health Disparities
NCI Center to Reduce Cancer Health Disparities/aacr.org
Jan 16, 2025, 23:27

The Basic Research in Cancer Health Disparities Program – NCI Center to Reduce Cancer Health Disparities

NCI Center to Reduce Cancer Health Disparities (CRCHD) shared a post on LinkedIn:

“The Basic Research in Cancer Health Disparities Program encourages applications investigating the biological/genetic contributors to cancer health disparities.

  • R01 awards fund more advanced projects that stem from preliminary studies/data. The upcoming due date for the R01 is February 5, 2025.
  • R21 awards are designed to support pilot and feasibility studies. The upcoming due date is February 16, 2025.

Learn more below!”

 The Basic Research in Cancer Health Disparities Program - NCI Center to Reduce Cancer Health Disparities

cancer Cancer Health Disparities Program fight against cancer Global fight against cancer NCI Center to Reduce Cancer Health Disparities OncoDaily Oncology
Special Coverage
Science
Sep 7, 2025, 12:35
Udhayvir Grewal Shares New Article on HER2 Prognostic Impact in mCRC
Insight
Sep 7, 2025, 12:30
Chadi Nabhan Shares Conversation with Timothy J. Brown on Colon Cancer Management
Voices
Sep 7, 2025, 12:28
ESCALIER: A Journey Connecting Specialists from the Paediatric Oncology Field with Patients - SIOPE
Insight
Sep 7, 2025, 12:21
Paolo Tarantino Highlights Positive PFS Results from DYNASTY-Breast02 Trial
Insight
Sep 7, 2025, 12:14
Sumanta K Pal: Terrific Presentation from John McGrane at IUCS 2025
Insight
Sep 7, 2025, 12:02
Oncology Nursing in Focus at the Armenian–German Oncology School
Insight
Sep 7, 2025, 11:56
MD Anderson and Phoenix SENOLYTIX in Cross-Licensing Deal to Advance Cell and Gene Therapies
Voices
Sep 7, 2025, 11:54
Roupen Odabashian: What Makes a Great Clinical Decision Support Tool?
Career Updates
Sep 7, 2025, 11:53
Desmond Murphy Starts a New Role as U.S. Oncology Assets Liaison at Servier Pharmaceuticals
Voices
Sep 7, 2025, 11:14
Francoise Mornex: Great Recognition of Solange Peters' Pivotal Role in IASLC and Lung Cancer
Immune Oncology
Sep 7, 2025, 11:13
10 Must-Read Posts in Immuno-Oncology This Week
Insight
Sep 7, 2025, 11:11
WCLC 2025 Highlights: FLAURA2 trial